Crossmark

Design of a randomized controlled trial of extended-release naltrexone versus daily buprenorphine-naloxone for opioid dependence in Norway (NTX-SBX)

Crossref DOI link: https://doi.org/10.1186/s40360-016-0061-1

Published Online: 2016-04-28

Published Print: 2016-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Kunøe, Nikolaj

Opheim, Arild

Solli, Kristin Klemmetsby

Gaulen, Zhanna

Sharma-Haase, Kamni

Latif, Zill-e-Huma

Tanum, Lars
Funding

Funding for this research was provided by:

Norges Forskningsråd (204725-3)

Helse Vest Regionalt Helseføretak (911709)
License Information

License valid from 2016-04-28